| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 147 | 0.0061 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 121 | 0.0025 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 195 | 0.0018 |
| 3 | Nucleoside Analog Antifungal [EPC] | 1 | 0.0007 |
| 4 | Protease Inhibitor [EPC] | 23 | 0.0005 |
| 5 | Cytochrome P450 3A Inhibitor [EPC] | 24 | 0.0004 |
| 6 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 8 | Polyene Antifungal [EPC] | 1 | 0.0000 |
| 9 | 5-alpha Reductase Inhibitor [EPC] | 1 | 0.0000 |
| 10 | Vitamin D [EPC] | 2 | 0.0000 |
| 11 | Vitamin B12 [EPC] | 2 | 0.0000 |
| 12 | Vitamin C [EPC] | 2 | 0.0000 |